For Wilkinson Barker Knauer partner Cheryl Tritt, a five-year campaign to win approval from the Federal Communications Commission came to a happy end Wednesday when the agency approved the use of spectrum for a potentially revolutionary medical treatment that could allow paralyzed people to regain the use of their limbs.
“It was one of the most satisfying days of my career,” said Tritt, who represents the Alfred Mann Foundation, which has developed technology that uses electric pulses from tiny implanted devices to stimulate the muscles of traumatic brain injury, stroke or spinal cord injury victims. The technology could also help people with multiple sclerosis and cerebral palsy.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
